Cargando…

Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses

As the global COVID-19 pandemic continues and new SARS-CoV-2 variants of concern emerge, vaccines remain an important tool for preventing the pandemic. The inactivated or subunit vaccines themselves generally exhibit low immunogenicity, which needs adjuvants to improve the immune response. We previo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiao, Yidan, Zhan, Yikang, Zhang, Yongli, Deng, Jieyi, Chen, Achun, Liu, Bingfeng, Zhang, Yiwen, Pan, Ting, Zhang, Wangjian, Zhang, Hui, He, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780597/ https://www.ncbi.nlm.nih.gov/pubmed/36569949 http://dx.doi.org/10.3389/fimmu.2022.992062

Ejemplares similares

An efficient and scalable synthesis of potent TLR2 agonistic PAM(2)CSK(4)
por: Kaur, Arshpreet, et al.
Publicado: (2018)

Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam(1)CSK(4) and Pam(3)CSK(4)
por: Megy, Simon, et al.
Publicado: (2020)

Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
por: Ma, Xiancai, et al.
Publicado: (2020)

Control of Methicillin-Resistant Staphylococcus aureus Pneumonia Utilizing TLR2 Agonist Pam3CSK4
por: Chen, Yi-Guo, et al.
Publicado: (2016)

Coinjection with TLR2 Agonist Pam3CSK4 Reduces the Pathology of Leishmanization in Mice
por: Huang, Lu, et al.
Publicado: (2015)

The TLR2/6 ligand PAM2CSK4 is a Th2 polarizing adjuvant in Leishmania major and Brugia malayi murine vaccine models
por: Halliday, Alice, et al.
Publicado: (2016)

Adjuvant Pam3CSk4 does not improve the immunization against Cryptococcus gattii infection in C57BL/6 mice
por: de Campos, Gabriela Yamazaki, et al.
Publicado: (2023)

A20 Is Critical for the Induction of Pam3CSK4-Tolerance in Monocytic THP-1 Cells
por: Hu, Jinyue, et al.
Publicado: (2014)

Differential Effects of the Toll-Like Receptor 2 Agonists, PGN and Pam3CSK4 on Anti-IgE Induced Human Mast Cell Activation
por: Yu, Yangyang, et al.
Publicado: (2014)

The Synthetic Bacterial Lipopeptide Pam3CSK4 Modulates Respiratory Syncytial Virus Infection Independent of TLR Activation
por: Nguyen, D. Tien, et al.
Publicado: (2010)

Regulation, targets and functions of CSK
por: Zhu, Shudong, et al.
Publicado: (2023)

Evaluation of different combination of pam2CSK4, poly (I:C) and imiquimod enhance immune responses to H9N2 avian influenza antigen in dendritic cells and duck
por: Zhang, Aiguo, et al.
Publicado: (2022)

Phosphate-mediated coanchoring of RBD immunogens and molecular adjuvants to alum potentiates humoral immunity against SARS-CoV-2
por: Rodrigues, Kristen A., et al.
Publicado: (2021)

Editorial: Regulation and dysfunction of CSK and CHK
por: Zhu, Shudong, et al.
Publicado: (2023)

TLR2 Ligand Pam3CSK4 Regulates MMP-2/9 Expression by MAPK/NF-κB Signaling Pathways in Primary Brain Microvascular Endothelial Cells
por: Zhu, Hongyan, et al.
Publicado: (2018)

Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
por: Li, Rong, et al.
Publicado: (2021)

Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo
por: Weir, Genevieve M., et al.
Publicado: (2017)

Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus
por: Li, Tiantian, et al.
Publicado: (2020)

The Toll-Like Receptor 2 Ligand Pam2CSK4 Activates Platelet Nuclear Factor-κB and Bruton’s Tyrosine Kinase Signaling to Promote Platelet-Endothelial Cell Interactions
por: Parra-Izquierdo, Iván, et al.
Publicado: (2021)

The inflammatory cytokine effect of Pam3CSK4 TLR2 agonist alone or in combination with Leishmania infantum antigen on ex-vivo whole blood from sick and resistant dogs
por: Martínez-Orellana, Pamela, et al.
Publicado: (2017)

Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
por: Cao, Yunlong, et al.
Publicado: (2022)

Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells
por: Lee, Sang-Hoon, et al.
Publicado: (2018)

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines
por: Cao, Yunlong, et al.
Publicado: (2021)

Regulation of the Src Family Kinases by Csk
por: Okada, Masato
Publicado: (2012)

CSK-mediated signalling by integrins in cancer
por: Maldonado, Horacio, et al.
Publicado: (2023)

Pro-inflammatory response ensured by LPS and Pam3CSK4 in RAW 264.7 cells did not improve a fungistatic effect on Cryptococcus gattii infection
por: de Campos, Gabriela Yamazaki, et al.
Publicado: (2020)

Siegesbeckia pubescens Makino inhibits Pam(3)CSK(4)-induced inflammation in RAW 264.7 macrophages through suppressing TLR1/TLR2-mediated NF-κB activation
por: Sang, Wei, et al.
Publicado: (2018)

SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function
por: Cui, Nan, et al.
Publicado: (2019)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Mitotic Activation of c‐Src Is Suppressed by Csk
por: Ohsato, Yoshiharu, et al.
Publicado: (1994)

Apoptosis regulation by the tyrosine-protein kinase CSK
por: Fortner, Andra, et al.
Publicado: (2022)

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2022)

RBD(206)-sc-dimer induced robust cross-neutralization against SARS-CoV-2 and variants of concern
por: Zhou, Chuge, et al.
Publicado: (2021)

Recovered COVID-19 patients with recurrent viral RNA exhibit lower levels of anti-RBD antibodies
por: Liu, Bingfeng, et al.
Publicado: (2020)

An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
por: Zhang, Haili, et al.
Publicado: (2022)

Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2
por: Lei, Hong, et al.
Publicado: (2020)

Screening of Efficient Adjuvants for the RBD-Based Subunit Vaccine of SARS-CoV-2
por: Shi, Juan, et al.
Publicado: (2023)

Gene Silencing and Haploinsufficiency of Csk Increase Blood Pressure
por: Lee, Hyeon-Ju, et al.
Publicado: (2016)

Impaired Humoral Immunity Identified in Inactivated SARS-CoV-2 Vaccine Recipients without Anti-Spike RBD Antibodies
por: Sun, Ting, et al.
Publicado: (2023)

Adipsin alleviates cardiac microvascular injury in diabetic cardiomyopathy through Csk-dependent signaling mechanism
por: Zhang, Xuebin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_je4tpsooh0dvtjejuo9k4np0rg